Cerenome, Inc. - Common Stock (CNSY)
Investment Snapshot
- P/B of 4.43 — trading above book value
- Piotroski F-Score 2/9 — signs of financial weakness
- Loss-making — negative ROE of -278.7%
- Revenue declining 10% annually
Cerenome, Inc. - Common Stock (CNSY) is a publicly traded company, listed on the NASDAQ , with a market capitalisation of $24 million . Key value metrics: P/B ratio 4.43, Piotroski F-Score 2 out of 9 .
Value Score
Key Metrics
Cerenome, Inc. - Common Stock — Fundamental Analysis Summary
On financial health, CNSY shows a weak Piotroski F-Score of 2/9, a signal of deteriorating financial health, and negative return on equity of -278.7%.
StockPik's composite Value Score for CNSY is 30/100 — reflecting current market or financial concerns. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
CNSY shows revenue declining at 10% year-over-year, with earnings declining at 72%.